Navigation Links
Aspirin Or NSAIDs Will not Prevent Colorectal Cancer

People who are at average risk for colorectal cancer, including those with a family history of the disease, should not take aspirin or non-steroidal// anti-inflammatory drugs (NSAIDs) to try to prevent the disease.

This is the first time the Task Force has made a recommendation related to taking medicines to prevent colorectal cancer. After reviewing the latest evidence on the topic, the Task Force found that the potential harms of taking more than 300 mg per day of aspirin or NSAIDs--which can include increased risks for stroke, intestinal bleeding or kidney failure--outweigh the potential benefits of colorectal cancer prevention.

Meanwhile, patients taking aspirin to prevent other conditions such as heart disease should continue to discuss the benefits with their clinicians, according to Task Force Chair Ned Calonge, M.D., who is also Chief Medical Officer and State Epidemiologist for the Colorado Department of Public Health and Information. The Task Force found good evidence that taking low doses of aspirin (usually less than 100 mg) can reduce risk for heart disease but does not reduce the rate of colorectal cancer. In 2002, the Task Force strongly recommended that clinicians discuss the use of aspirin as a preventive medication with adults who are at increased risk for heart disease and that those discussions should address the potential benefits and harms of aspirin therapy.

Colorectal cancer is the third most common type of cancer in men and women and is the second-leading cause of cancer-related deaths in the United States. About 56,000 Americans die from colorectal cancer and 150,000 new cases are diagnosed each year. Between 5 percent and 6 percent of people develop colorectal cancer in their lifetime, and the majority of those diagnosed are over the age of 50.

Twenty percent of individuals diagnosed with colorectal cancer have a first- or second-degree relative with the disease, and African Americans have th
'"/>




Page: 1 2

Related medicine news :

1. What happens when Asthmatics consume Aspirin?
2. Aspirin reduces deaths
3. Aspirin and Warfarin Are Equally Effective for Stroke Prevention
4. Aspirin - a drug after one’s own hear
5. Aspirin deflated
6. Aspirin surpasses Modern Anti-clotting Drugs
7. Night Time Aspirin Regimen Found to Reduce Blood Pressure
8. Aspirin Lowers Leukemia Risk
9. Aspirin usage linked with pancreatic cancer
10. Aspirin Found To Reduce The Risk Of Colon Cancer
11. Aspirin Induced Asthma , A Little-Known Inducer
Post Your Comments:
(Date:1/7/2009)... , (Baltimore) The Greenwall Foundation recently...kins Berman Institute of Bioethics a grant that wi... to explore the ethical challenges health professi...affected by life-threatening neuromuscular disease...udy grew out of the work of the international Hear...
(Date:1/7/2009)... , Rx-tra Savings is Available at Albertsons store...ISE, Idaho, Jan. 7 Albertson,s LLC announced an e...iption discount program today by introducing a new...0 generic drugs. In addition, Albertsons has adde... 500 drugs that are already covered by this discou...
(Date:1/7/2009)... , ALBANY, Ore., Jan. 7 Synthetech, Inc.,(OTC...Performance Improvement,Awards for their outstandi...ealth, Safety, & Security (EHS&S) Planning...The Silver Awards are presented by the Synthetic O...and sponsored by ChemStewards,SOCMA,s EHS&S im...
(Date:1/7/2009)... , OWINGS MILLS, Md., Jan. 7 Medifast, Inc. (NYSE...s program, today announced they,ve been named a Fu...edifast is a 2007 and 2009 winner of this award. ...st growing companies in the Greater Baltimore area...nounced on December 16, 2008 that The Company expe...
Breaking Medicine News(10 mins):Health News:Study to explore ethical challenges health professionals face while caring for children with LTNMDs 2Health News:Study to explore ethical challenges health professionals face while caring for children with LTNMDs 3Health News:Albertson's LLC Launches $10.99 for 90-day Supply of Generic Drugs as Part of Rx-tra Savings Prescription Discount Program 2Health News:Synthetech Earns National Recognition for Performance Improvement Program 2Health News:Synthetech Earns National Recognition for Performance Improvement Program 3Health News:Medifast Named Baltimore SmartCEO Future 50 Company for Second Time 2
...Spraying salty water (saline) into your nose can h...at accompany long-term infections of the nasal pas...rsistent infection of the nasal passages (chronic ...nd yogic forms of healthcare recommend spraying sa...
...tematic Review,there are no high quality data to a...tes work in people who have just been told they h... on exercise seems to be one way of improving bloo... a person at danger of having elevated levels of s...
... - a huge pink hot air balloon - is set Friday to ...areness . The balloon - which organisers hope will...oned by seven local branches of the public medical...tival in Lichtenvoorde, a small town near Almelo i...
...led a plan for coping with a pandemic flu outbreak...ty to detect a disease outbreak and track its prog...ecided that it will not close the borders if a pan...in the world. Says Dr. Rajeev Venkayya, special as...
Other Medicine News:Health News:Less Information on Dietary Treatment in Type2 Diabetes 2Health News:Americas Preparations For Flu Outbreak Still Incomplete 2
(Date:1/7/2009)...Tiantan Puhua Hospital Stem Cells Center ( http://...using stem cells to effectively treat neurological...ienced additions to its medical and research staff...t capabilities for growing numbers of incoming int...e the distinguished Dr. Jiang Ping, who was named ...
(Date:1/6/2009)...sults from prior U.S., U.K. and China Trials , ,...s, Inc. (VTI), a development stage company targeti...nt has begun for a randomized, controlled, multi-c...Extracorporeal Liver Assist Device (ELAD) as a tre... under three protocols. The study is open for enro...
(Date:1/6/2009)...e/ -- In recent controlled studies conducted by Dr...ists found that the patented ingredient in Glyc,n ... ingredient to increase levels of nitric oxide (NO...trate (NOx) in human subjects. , , Nitric oxide...blood flow to the skeletal muscles. This is signi...
(Date:1/6/2009)...re-USNewswire/ -- Sequella, Inc., a clinical-stage...epidemic potential, announced today that SQ109, it...losis (TB), was the first drug approved for evalua...to Dynport Vaccine Company LLC and Quintiles Trans...stitute of Allergy and Infectious Diseases (NIAID)...
Breaking Medicine Technology:Stem Cell Treatment Leader Tiantan Puhua Adds Experienced International Medical Staff for Expanding Numbers of Patients 2Stem Cell Treatment Leader Tiantan Puhua Adds Experienced International Medical Staff for Expanding Numbers of Patients 3ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers 2ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers 3US Testing Proves Glyc'n Go(TM) Increases NO in the Blood Stream 2Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program 2Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program 3Oncolytics Biotech Inc Completes Dose Escalation in Combination REOLYSIN 28R 29 Docetaxel Trial 7068 1Oncolytics Biotech Inc Completes Dose Escalation in Combination REOLYSIN 28R 29 Docetaxel Trial 7068 2Oncolytics Biotech Inc Completes Dose Escalation in Combination REOLYSIN 28R 29 Docetaxel Trial 7068 3Surviving the revolution easier than withstanding human use and abuse 4415 1Surviving the revolution easier than withstanding human use and abuse 4415 2Surviving the revolution easier than withstanding human use and abuse 4415 3USC researchers identify alternate pathway that leads to palate development 4411 1USC researchers identify alternate pathway that leads to palate development 4411 2USC researchers identify alternate pathway that leads to palate development 4411 3Merrimack Pharmaceuticals Initiates Enrollment in a Phase 1 Study of MM 121 an ErbB3 Antagonist 7062 1Merrimack Pharmaceuticals Initiates Enrollment in a Phase 1 Study of MM 121 an ErbB3 Antagonist 7062 2Merrimack Pharmaceuticals Initiates Enrollment in a Phase 1 Study of MM 121 an ErbB3 Antagonist 7062 3
...the CDC that none of its influenza vaccine (Fluvir...ted States for the current influenza season. In th...e anticipated American vaccine supply, medical off...gly alarmed about the scarcity of vaccine and the ...e seen if virulent new strains of flu or an abnorm...
...f rapid, easy-to-use diagnostic tests, many assays...ace to help clinicians assess dosage appropriatene...ence of drugs of abuse. Some of these products req...s are suitable for point of care use by medical pr..., Therapeutic drug monitoring measures the serum ...
Other Medicine Technology:Rapid Flu Tests May Prove Especially Helpful This Season 2Rapid Flu Tests May Prove Especially Helpful This Season 3Monitoring Options Expand for Therapeutic Agents and Drugs of Abuse 2Monitoring Options Expand for Therapeutic Agents and Drugs of Abuse 3Monitoring Options Expand for Therapeutic Agents and Drugs of Abuse 4
Round, knurled handle. Overall length 120 mm. Designed for iris retraction and lens manipulation. Roughened posterior surface may be used to polish capsule.
Button shape tip, round serrated handle, dull finish, overall length 130 mm.
...n Super EX is a rigid gas lens with high oxygen pe... as hard contact lens, it can provide superior vis...nst astigmatism. The key feature of Menicon Super ...te, Siloxanylmethacrylate and methacrylic acid, wh...
Magniclear is the first presbyopic lens to combine the clear distance optics of a spherical lens, the intermediate visual performance of a multifocal and the predictably crisp, near power of a bifoca
Medicine Products: